Entrepreneurs Investment Meet

Pharmaceutical companies are actively developing analogues of existing antibiotic classes based on innovative approaches to fight bacterial infections. Key players operating in the global antibiotic market include Pfizer Inc., Astellas Pharma, Inc, Roche, Novartis AG, Bristol-Myers Squibb Co., Bayer HealthCare AG, Abbott Laboratories, MiddleBrook Pharmaceuticals, Takeda Pharmaceutical Company, Ltd., Daiichi Sankyo Company, Ltd., GlaxoSmithKline Plc, Eli Lilly and Co., and Kyorin Pharmaceutical Co., Ltd. Supportive government legislations, such as the Generating Antibiotics Incentives Now (GAIN) Act are expected to expedite the approval process. GAIN Act has provisions which facilitate development of therapy against antibiotic resistant pathogens.

 

    Related Conference of Entrepreneurs Investment Meet

    March 04-05, 2019

    10th Molecular Immunology & Immunogenetics Congress

    Barcelona, Spain
    March 18-19, 2019

    11th Global Summit on Immunology and Cell Biology

    Sydney, Australia
    March 18-19, 2019

    13th International Congress on Autoimmunity

    Brisbane, Australia
    June 13-14, 2019 |

    10th European Immunology Conference

    Berlin, Germany
    July 24-25, 2019

    11th World Congress and Expo on Immunology

    Vancouver, Canada
    July 29-30 2019

    6th International Conference on Parasitology & Microbiology

    Amsterdam, Netherlands
    October 21-22, 2019

    12th Annual Congress on Immunology & Immunogenetics

    Rome, Italy
    November 22-23, 2019 |

    World Conference on Vaccine and Immunology

    Dubai, UAE

    Entrepreneurs Investment Meet Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in